Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Its portfolio includes medicines and vaccines across oncology, internal medicine, hospital products, and rare disease.
Pfizer Inc. operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for PFE.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). PFE Stock Intelligence Report. [stoxpulse.com/stocks/pfe]
Disclaimer: The information on this page about Pfizer Inc. (PFE) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Pfizer Inc..
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 11%
Jun 30
BOURLA bought 38K shares
Aug 12
DAMICO sold 3K shares
Aug 5
AbbVie vs. Pfizer: Which Healthcare Stock Is a Bet...
11h ago
Was JNJ Stock Rally Actually Its Own?
13h ago
StoxPulse AI results for PFE: Pulse Score 50/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$162.16B
P/E Ratio
18.2
EPS
$-0.29
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sep 25
+36.0%
Dec 25
+14.3%
Mar 26
+3.5%
Jun 26
+11.4%
Beat estimates 4 of 4 quarters (100%)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Its portfolio includes medicines and vaccines across oncology, internal medicine, hospital products, and rare disease.
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Was JNJ Stock Rally Actually Its Own?
Pfizer’s Stock Has Been Crushed—Is Its 6% Dividend Finally Worth Buying?
AMGN's MariTide: Can Convenience Drive its Obesity Market Share?
Trailing rivals, AbbVie scores win with dual-acting myeloma drug
Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
Pfizer (PFE) Stock Looks Fully Valued As Earnings Run Ahead Of Value
Pfizer (PFE) After FDA Vaccine Approval Faces A Fair Value Reality Check